An2 Therapeutics Inc (ANTX)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
AN2 Therapeutics Inc Continues to Shine in Stock Market with Exciting Second Quarter Performance
Very steep Decline at An2 Therapeutics Inc over the October to December 31 2022 span
reported Revenue of $0.466 million, in the fiscal third quarter of 2022
The company declared that revenue has tumbled, amid the fiscal first quarter of 2022